EGFR and central nervous system cancer: Yang et al. (Yang et al., 2013) developed an advanced NGO drug delivery nanoparticle co-loaded epirubicin (EPI) and anti-EGFR antibody (C255) with PEG connection for blocking EGFR growth signal to treat glioma.